These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37173550)

  • 21. Comprehensive molecular and clinical characterization of
    Bertrums EJM; Smith JL; Harmon L; Ries RE; Wang YJ; Alonzo TA; Menssen AJ; Chisholm KM; Leonti AR; Tarlock K; Ostronoff F; Pogosova-Agadjanyan EL; Kaspers GJL; Hasle H; Dworzak M; Walter C; Muhlegger N; Morerio C; Pardo L; Hirsch B; Raimondi S; Cooper TM; Aplenc R; Gamis AS; Kolb EA; Farrar JE; Stirewalt D; Ma X; Shaw TI; Furlan SN; Brodersen LE; Loken MR; Van den Heuvel-Eibrink MM; Zwaan CM; Triche TJ; Goemans BF; Meshinchi S
    Haematologica; 2023 Aug; 108(8):2044-2058. PubMed ID: 36815378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
    Ostronoff F; Othus M; Gerbing RB; Loken MR; Raimondi SC; Hirsch BA; Lange BJ; Petersdorf S; Radich J; Appelbaum FR; Gamis AS; Alonzo TA; Meshinchi S
    Blood; 2014 Oct; 124(15):2400-7. PubMed ID: 25145343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features of patients with acute myeloid leukaemia and the NUP98::NSD1 fusion gene.
    Wu A; Liu Y; Wei S; Li Y; Liu K; Fang Q; Lin D; Gong B; Zhang G; Gong X; Liu B; Wang Y; Mi Y; Wei H; Wang J
    Int J Lab Hematol; 2023 Aug; 45(4):589-591. PubMed ID: 36751862
    [No Abstract]   [Full Text] [Related]  

  • 27. Refractory pediatric acute myeloid leukemia expressing NUP98-NSD1 fusion gene responsive to chemotherapy combined with venetoclax and decitabine.
    Xu H; Yu H; Xu J; Zhou F; Tang S; Feng X; Luo Q; Zhang B; Wu X; Jin R; Chen H
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30021. PubMed ID: 36184746
    [No Abstract]   [Full Text] [Related]  

  • 28. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis.
    Xu H; Valerio DG; Eisold ME; Sinha A; Koche RP; Hu W; Chen CW; Chu SH; Brien GL; Park CY; Hsieh JJ; Ernst P; Armstrong SA
    Cancer Cell; 2016 Dec; 30(6):863-878. PubMed ID: 27889185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
    Shimada A; Iijima-Yamashita Y; Tawa A; Tomizawa D; Yamada M; Norio S; Watanabe T; Taga T; Iwamoto S; Terui K; Moritake H; Kinoshita A; Takahashi H; Nakayama H; Koh K; Goto H; Kosaka Y; Saito AM; Kiyokawa N; Horibe K; Hara Y; Oki K; Hayashi Y; Tanaka S; Adachi S
    Int J Hematol; 2018 May; 107(5):586-595. PubMed ID: 29330746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
    Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
    Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NUP98 dysregulation in myeloid leukemogenesis.
    Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G
    Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The First Korean Case of
    Lim HJ; Lee JH; Lee YE; Baek HJ; Kook H; Park JH; Lee SY; Choi HW; Choi HJ; Kee SJ; Shin JH; Shin MG
    Ann Lab Med; 2021 Jul; 41(4):443-446. PubMed ID: 33536367
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia: A pediatric case report.
    Wen X; Wu Y; Huang P; Zheng H
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30308. PubMed ID: 36965174
    [No Abstract]   [Full Text] [Related]  

  • 34. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells.
    Fan D; Li Z; Zhang X; Yang Y; Yuan X; Zhang X; Yang M; Zhang Y; Xiong D
    J Hematol Oncol; 2015 Feb; 8():18. PubMed ID: 25879549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients.
    Shah A; Sharma A; Katiyar S; Gupta A; Chaturvedi CP
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553008
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
    Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
    Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent inhibition of NSD1 histone methyltransferase.
    Huang H; Howard CA; Zari S; Cho HJ; Shukla S; Li H; Ndoj J; González-Alonso P; Nikolaidis C; Abbott J; Rogawski DS; Potopnyk MA; Kempinska K; Miao H; Purohit T; Henderson A; Mapp A; Sulis ML; Ferrando A; Grembecka J; Cierpicki T
    Nat Chem Biol; 2020 Dec; 16(12):1403-1410. PubMed ID: 32868895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11)(p11;p15) and expression pattern of NSD family genes.
    Taketani T; Taki T; Nakamura H; Taniwaki M; Masuda J; Hayashi Y
    Cancer Genet Cytogenet; 2009 Apr; 190(2):108-12. PubMed ID: 19380029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
    Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
    Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
    Palmqvist L; Pineault N; Wasslavik C; Humphries RK
    PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.